{"entity":{"type":"insider","cik":"0001434099","url":"/insider/0001434099","json_url":"/insider/0001434099.json","name":"Brandt Peter C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":8,"first":"2008-05-15","last":"2022-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Brandt Peter C.","source":"filing","n_filings":8,"first_seen":"2008-05-15","last_seen":"2022-08-18"}],"transactions":[{"id":6825291,"accession":"0001209191-22-046598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046598","line_url":"/filing/0001209191-22-046598#line-1","is_derivative":false,"issuer_cik":"0001434099","issuer_name":"IN8BIO, INC.","issuer_ticker":"INAB","issuer_name_source":null,"issuer_url":"/issuer/0001434099","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105263.0,"shares_display":"105,263","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":199999.7,"total_display":"199,999.70","total_whole":"200,000","shares_owned_after":182473.0,"shares_owned_after_display":"182,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":2452760,"accession":"0001209191-12-014552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-014552","line_url":"/filing/0001209191-12-014552","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.09982,"price_display":"20.10","price_state":"stated","total_value":200998.2,"total_display":"200,998.20","total_whole":"200,998","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-28","filed_date":"2012-03-01","scope":"insider","n_lines":2},{"id":9042603,"accession":"0001140361-11-045494","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001140361-11-045494","line_url":"/filing/0001140361-11-045494","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80000.0,"shares_display":"80,000","price_per_share":1.21963375,"price_display":"1.22","price_state":"stated","total_value":97570.7,"total_display":"97,570.70","total_whole":"97,571","shares_owned_after":131700.0,"shares_owned_after_display":"131,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-09","filed_date":"2011-09-12","scope":"insider","n_lines":4},{"id":9042599,"accession":"0001140361-11-045494","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-11-045494","line_url":"/filing/0001140361-11-045494","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":1.0952096,"price_display":"1.10","price_state":"stated","total_value":49284.432,"total_display":"49,284.43","total_whole":"49,284","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-08","filed_date":"2011-09-12","scope":"insider","n_lines":6},{"id":9060769,"accession":"0001096738-11-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001096738-11-000018","line_url":"/filing/0001096738-11-000018#line-1","is_derivative":false,"issuer_cik":"0001096738","issuer_name":"EPOCRATES INC","issuer_ticker":"EPOC","issuer_name_source":null,"issuer_url":"/issuer/0001096738","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14568.0,"shares_display":"14,568","price_per_share":9.777,"price_display":"9.78","price_state":"stated","total_value":142431.336,"total_display":"142,431.34","total_whole":"142,431","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-07","filed_date":"2011-09-09","scope":"insider"},{"id":8886754,"accession":"0001140361-11-045204","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-11-045204","line_url":"/filing/0001140361-11-045204#line-8","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":5200.0,"total_display":"5,200.00","total_whole":"5,200","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-07","filed_date":"2011-09-08","scope":"insider"},{"id":9021098,"accession":"0001096738-11-000017","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001096738-11-000017","line_url":"/filing/0001096738-11-000017","is_derivative":false,"issuer_cik":"0001096738","issuer_name":"EPOCRATES INC","issuer_ticker":"EPOC","issuer_name_source":null,"issuer_url":"/issuer/0001096738","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10432.0,"shares_display":"10,432","price_per_share":9.583203604294479,"price_display":"9.58","price_state":"stated","total_value":99971.98,"total_display":"99,971.98","total_whole":"99,972","shares_owned_after":4900.0,"shares_owned_after_display":"4,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-06","filed_date":"2011-09-08","scope":"insider","n_lines":8},{"id":8886752,"accession":"0001140361-11-045204","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001140361-11-045204","line_url":"/filing/0001140361-11-045204","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.946125,"price_display":"0.95","price_state":"stated","total_value":18922.5,"total_display":"18,922.50","total_whole":"18,923","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-06","filed_date":"2011-09-08","scope":"insider","n_lines":7},{"id":2633376,"accession":"0001209191-08-049927","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-049927","line_url":"/filing/0001209191-08-049927","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":12.389173,"price_display":"12.39","price_state":"stated","total_value":247783.46,"total_display":"247,783.46","total_whole":"247,783","shares_owned_after":295000.0,"shares_owned_after_display":"295,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider","n_lines":4},{"id":3968946,"accession":"0001209191-08-030424","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-08-030424","line_url":"/filing/0001209191-08-030424","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":195800.0,"total_display":"195,800.00","total_whole":"195,800","shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-14","filed_date":"2008-05-15","scope":"insider","n_lines":2},{"id":3968944,"accession":"0001209191-08-030424","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-030424","line_url":"/filing/0001209191-08-030424","is_derivative":false,"issuer_cik":"0000815838","issuer_name":"NOVEN PHARMACEUTICALS INC","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0000815838","owner_cik":"0001434099","owner_name":"Brandt Peter C.","owner_display_name":"Brandt Peter C.","owner_url":"/insider/0001434099","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock ($.0001 par value)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.814376,"price_display":"9.81","price_state":"stated","total_value":49071.88,"total_display":"49,071.88","total_whole":"49,072","shares_owned_after":255000.0,"shares_owned_after_display":"255,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-13","filed_date":"2008-05-15","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":40,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001740279","name":"IN8BIO, INC.","url":"/issuer/0001740279","role":"Director","n_filings":1,"first_seen":"2022-08-18","last_seen":"2022-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Director","n_filings":1,"first_seen":"2012-03-01","last_seen":"2012-03-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001228627","name":"REXAHN PHARMACEUTICALS, INC.","url":"/issuer/0001228627","role":"Director","n_filings":2,"first_seen":"2011-09-08","last_seen":"2011-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001096738","name":"EPOCRATES INC","url":"/issuer/0001096738","role":"Director","n_filings":2,"first_seen":"2011-09-08","last_seen":"2011-09-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000815838","name":"NOVEN PHARMACEUTICALS INC","url":"/issuer/0000815838","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2008-05-15","last_seen":"2008-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001434099","retrieved_at":"2026-08-22T21:56:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}